Cathepsin K osteoporosis trials, pycnodysostosis and mouse deficiency models: Commonalities and differences
出版年份 2016 全文链接
标题
Cathepsin K osteoporosis trials, pycnodysostosis and mouse deficiency models: Commonalities and differences
作者
关键词
-
出版物
Expert Opinion on Drug Discovery
Volume 11, Issue 5, Pages 457-472
出版商
Informa Healthcare
发表日期
2016-03-22
DOI
10.1517/17460441.2016.1160884
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Structural requirements for the collagenase and elastase activity of cathepsin K and its selective inhibition by an exosite inhibitor
- (2015) Vidhu Sharma et al. BIOCHEMICAL JOURNAL
- Effect of SI-591, a new class of cathepsin K inhibitor with peptidomimetic structure, on bone metabolism in vitro and in vivo
- (2015) Toshiaki Fujii et al. BONE
- A novel approach to inhibit bone resorption: exosite inhibitors against cathepsin K
- (2015) Preety Panwar et al. BRITISH JOURNAL OF PHARMACOLOGY
- Odanacatib Restores Trabecular Bone of Skeletally Mature Female Rabbits With Osteopenia but Induces Brittleness of Cortical Bone: A Comparative Study of the Investigational Drug With PTH, Estrogen, and Alendronate
- (2015) Mohd Parvez Khan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Odanacatib increases mineralized callus during fracture healing in a rabbit ulnar osteotomy model
- (2015) Brenda L. Pennypacker et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Papilledema From Craniosynostosis in Pycnodysostosis
- (2015) Sung-eun E. Kyung et al. PEDIATRIC NEUROLOGY
- Complexity of cancer protease biology: Cathepsin K expression and function in cancer progression
- (2015) Urška Verbovšek et al. SEMINARS IN CANCER BIOLOGY
- Odanacatib: a review of its potential in the management of osteoporosis in postmenopausal women
- (2015) Roland D. Chapurlat Therapeutic Advances in Musculoskeletal Disease
- Effects of eight-month treatment with ONO-5334, a cathepsin K inhibitor, on bone metabolism, strength and microstructure in ovariectomized cynomolgus monkeys
- (2014) Yasuo Ochi et al. BONE
- Increased fracture callus mineralization and strength in cathepsin K knockout mice
- (2014) Michael A. Gentile et al. BONE
- Inhibition of bone resorption by the cathepsin K inhibitor odanacatib is fully reversible
- (2014) Y. Zhuo et al. BONE
- Treatment of postmenopausal osteoporosis with odanacatib
- (2014) Roland D Chapurlat EXPERT OPINION ON PHARMACOTHERAPY
- Novel Mutation and White Matter Involvement in an Indian Child with Pycnodysostosis
- (2014) Ankur Singh et al. INDIAN JOURNAL OF PEDIATRICS
- Efficacy and safety of odanacatib treatment for patients with osteoporosis: a meta-analysis
- (2014) Shi Feng et al. JOURNAL OF BONE AND MINERAL METABOLISM
- RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer
- (2014) Fangfang Wang et al. JOURNAL OF CONTROLLED RELEASE
- Salvia miltiorrhiza: An ancient Chinese herbal medicine as a source for anti-osteoporotic drugs
- (2014) Yubo Guo et al. JOURNAL OF ETHNOPHARMACOLOGY
- Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial
- (2014) H. G. Bone et al. OSTEOPOROSIS INTERNATIONAL
- Structural basis of collagen fiber degradation by cathepsin K
- (2014) Adeleke H. Aguda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel allosteric mechanism in the cysteine peptidase cathepsin K discovered by computational methods
- (2014) Marko Novinec et al. Nature Communications
- Exome sequencing identifies CTSK mutations in patients originally diagnosed as intermediate osteopetrosis
- (2013) Alessandra Pangrazio et al. BONE
- A novel mutation in two families with pycnodysostosis
- (2013) Taha R. Ozdemir et al. CLINICAL DYSMORPHOLOGY
- Antiangiogenic effects of marine sponge derived compounds on cancer
- (2013) Kalimuthu Senthilkumar et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Potential Antiosteoporotic Agents from Plants: A Comprehensive Review
- (2013) Min Jia et al. Evidence-based Complementary and Alternative Medicine
- Cathepsin K Knockout Alleviates Pressure Overload–Induced Cardiac Hypertrophy
- (2013) Yinan Hua et al. HYPERTENSION
- Cathepsin K Activity Controls Injury-Related Vascular Repair in Mice
- (2013) Lina Hu et al. HYPERTENSION
- The Effect of the Cathepsin K Inhibitor ONO-5334 on Trabecular and Cortical Bone in Postmenopausal Osteoporosis: The OCEAN Study
- (2013) Klaus Engelke et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of ONO-5334 on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Osteoporosis: 2-Year Results From the OCEAN Study
- (2013) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation
- (2013) Sutada Lotinun et al. JOURNAL OF CLINICAL INVESTIGATION
- Differential expression of cathepsins K, S and V between young and aged Caucasian women skin epidermis
- (2013) Juliette Sage et al. MATRIX BIOLOGY
- Odanacatib in postmenopausal women with low bone mineral density: a review of current clinical evidence
- (2013) Cristiano A. F. Zerbini et al. Therapeutic Advances in Musculoskeletal Disease
- Effect of the selective cathepsin K inhibitor MIV-711 on bone resorption and cartilage degradation biomarkers and on knee joint pathology in dogs subjected to partial medial meniscectomy, an experimental model of osteoarthritis
- (2012) E. Lindstrom⁎ et al. BONE
- Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics - results from single oral dose studies in healthy volunteers
- (2012) S. Aubrey Stoch et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Disruption of the V-ATPase Functionality as a Way to Uncouple Bone Formation and Resorption - A Novel Target for Treatment of Osteoporosis
- (2012) C. S. Thudium et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Cathepsin K Knockout Mitigates High-Fat Diet-Induced Cardiac Hypertrophy and Contractile Dysfunction
- (2012) Y. Hua et al. DIABETES
- Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study
- (2012) Bente Langdahl et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Obesity in pycnodysostosis due to UPD1: Possible effect of an imprinted gene on chromosome 1
- (2011) Debora Bertola et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Osteoarthritic change is delayed in a Ctsk-knockout mouse model of osteoarthritis
- (2011) Eiji Kozawa et al. ARTHRITIS AND RHEUMATISM
- Cathepsin K deficiency in mice induces structural and metabolic changes in the central nervous system that are associated with learning and memory deficits
- (2011) Stephanie Dauth et al. BMC NEUROSCIENCE
- Pycnodysostosis with craniosynostosis
- (2011) Hugo P. Caracas et al. CLINICAL DYSMORPHOLOGY
- Cathepsin K deficiency aggravates lung injury in hyperoxia-exposed newborn mice
- (2011) Jonni Knaapi et al. EXPERIMENTAL LUNG RESEARCH
- Discontinuation of odanacatib and other osteoporosis treatments: Here today and gone tomorrow?
- (2011) Douglas C Bauer JOURNAL OF BONE AND MINERAL RESEARCH
- Safety and efficacy of the cathepsin K inhibitor ONO-5334 in postmenopausal osteoporosis: The OCEAN study
- (2011) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys
- (2011) Patricia J Masarachia et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Odanacatib treatment increases hip bone mass and cortical thickness by preserving endocortical bone formation and stimulating periosteal bone formation in the ovariectomized adult rhesus monkey
- (2011) Tara Cusick et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Pharmacodynamic Effects on Biochemical Markers of Bone Turnover and Pharmacokinetics of the Cathepsin K Inhibitor, ONO-5334, in an Ascending Multiple-Dose, Phase 1 Study
- (2011) Shinichi Nagase et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib
- (2011) Thomas M. Rnger et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis
- (2011) Aline G. Costa et al. Nature Reviews Rheumatology
- "MY PKU": increasing self-management in patients with phenylketonuria. A randomized controlled trial
- (2011) Amber E ten Hoedt et al. Orphanet Journal of Rare Diseases
- Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys
- (2011) C. Jerome et al. OSTEOPOROSIS INTERNATIONAL
- Severe developmental bone phenotype in ClC-7 deficient mice
- (2010) A.V. Neutzsky-Wulff et al. DEVELOPMENTAL BIOLOGY
- Craniosynostosis: A rare complication of pycnodysostosis
- (2010) Sara Osimani et al. European Journal of Medical Genetics
- Future of anticathepsin K drugs: dual therapy for skeletal disease and atherosclerosis?
- (2010) Izabela Podgorski Future Medicinal Chemistry
- Structure-Activity Analysis of Cathepsin K/Chondroitin 4-Sulfate Interactions
- (2010) Maia M. Cherney et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect
- (2010) John A Eisman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Near Normalization of Adult Height and Body Proportions by Growth Hormone in Pycnodysostosis
- (2010) Anya Rothenbühler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The vacuolar ATPase in bone cells: a potential therapeutic target in osteoporosis
- (2010) Feng-Lai Yuan et al. MOLECULAR BIOLOGY REPORTS
- Pharmacological inhibitors to identify roles of cathepsin K in cell-based studies: a comparison of available tools
- (2009) Sylvie Desmarais et al. BIOLOGICAL CHEMISTRY
- Nanostructured polyelectrolyte multilayer drug delivery systems for bone metastasis prevention
- (2009) Florence Daubiné et al. BIOMATERIALS
- Treatment with a Potent Cathepsin K Inhibitor Preserves Cortical and Trabecular Bone Mass in Ovariectomized Monkeys
- (2009) G. B. Stroup et al. CALCIFIED TISSUE INTERNATIONAL
- Effect of the Cathepsin K Inhibitor Odanacatib on Bone Resorption Biomarkers in Healthy Postmenopausal Women: Two Double-Blind, Randomized, Placebo-Controlled Phase I Studies
- (2009) S A Stoch et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cathepsin K inhibitors for osteoporosis and potential off-target effects
- (2009) Dieter Brömme et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Sustained delivery and efficacy of polymeric nanoparticles containing osteopontin and bone sialoprotein antisenses in rats with breast cancer bone metastasis
- (2009) Victoria Elazar et al. INTERNATIONAL JOURNAL OF CANCER
- Odanacatib, a Cathepsin-K Inhibitor for Osteoporosis: A Two-Year Study in Postmenopausal Women With Low Bone Density
- (2009) Henry G Bone et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The cathepsin K inhibitor AAE581 induces morphological changes in osteoclasts of treated patients
- (2009) Daniel Chappard et al. MICROSCOPY RESEARCH AND TECHNIQUE
- Cathepsin K generates enkephalin from β-endorphin: A new mechanism with possible relevance for schizophrenia
- (2009) Uwe Lendeckel et al. NEUROCHEMISTRY INTERNATIONAL
- Cleavage of Type II Collagen by Cathepsin K in Human Osteoarthritic Cartilage
- (2008) Valeria M. Dejica et al. AMERICAN JOURNAL OF PATHOLOGY
- Deficiency and Inhibition of Cathepsin K Reduce Body Weight Gain and Increase Glucose Metabolism in Mice
- (2008) Min Yang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor–transgenic mice
- (2008) Uta Schurigt et al. ARTHRITIS AND RHEUMATISM
- Erosive arthritis in a patient with pycnodysostosis: An experiment of nature
- (2008) Mari Ainola et al. ARTHRITIS AND RHEUMATISM
- Role of cathepsin K in structural changes in brachiocephalic artery during progression of atherosclerosis in apoE-deficient mice
- (2008) Andriy O. Samokhin et al. ATHEROSCLEROSIS
- The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K
- (2008) Jacques Yves Gauthier et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Bone density, strength, and formation in adult cathepsin K (−/−) mice
- (2008) B. Pennypacker et al. BONE
- Severe Snoring in a Child with Pycnodysostosis Treated with a Bilateral Rib Graft
- (2008) Natacha Teissier et al. CLEFT PALATE-CRANIOFACIAL JOURNAL
- Mechanisms of the Anabolic Effects of Teriparatide on Bone: Insight From the Treatment of a Patient With Pycnodysostosis
- (2008) Pascale Chavassieux et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Role of the hemopexin domain of matrix metalloproteinases in cell migration
- (2008) Antoine Dufour et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The Crystal and Molecular Structures of a Cathepsin K:Chondroitin Sulfate Complex
- (2008) Zhenqiang Li et al. JOURNAL OF MOLECULAR BIOLOGY
- Drug-induced morphea: Report of a case induced by balicatib and review of the literature
- (2008) Anna Peroni et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Cathepsin K inhibitors prevent matrix-derived growth factor degradation by human osteoclasts
- (2007) Karen Fuller et al. BONE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search